Moreover, since CD8 + T cells’ cytotoxic activity is responsible for rejection the anti-tumor effects of cancer immunotherapy, we therefore asked whether xenogeneic urothelial cell immunotherapy could affect T cells’ cytotoxic activity function by determining immune effector cell-mediated target cell cytotoxicity. Here, CD8A is linked to cancer.